Glaukos Corporation Announces Second Quarter 2016 Financial Results
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced financial results for the second quarter ended June 30, 2016. Key highlights include: Achieved 61% net sales growth to $28.6 million in the second quarter of 2016, compared to $17.8 million in the second quarter of 2015 Expanded gr
